G. ŞİRİN Et Al. , "Is There Any Difference Between PEG IFN Alpha 2a or Alpha 2b Plus Ribavirin for HCV Patient in Real Life Conditions," Asian Pacific Association Study of The Liver (APASL) Congress , 2014
ŞİRİN, G. Et Al. 2014. Is There Any Difference Between PEG IFN Alpha 2a or Alpha 2b Plus Ribavirin for HCV Patient in Real Life Conditions. Asian Pacific Association Study of The Liver (APASL) Congress .
ŞİRİN, G., ŞENTÜRK, Ö., ÇELEBİ, A., & HÜLAGÜ, S., (2014). Is There Any Difference Between PEG IFN Alpha 2a or Alpha 2b Plus Ribavirin for HCV Patient in Real Life Conditions . Asian Pacific Association Study of The Liver (APASL) Congress
ŞİRİN, GÖKTUĞ Et Al. "Is There Any Difference Between PEG IFN Alpha 2a or Alpha 2b Plus Ribavirin for HCV Patient in Real Life Conditions," Asian Pacific Association Study of The Liver (APASL) Congress, 2014
ŞİRİN, GÖKTUĞ Et Al. "Is There Any Difference Between PEG IFN Alpha 2a or Alpha 2b Plus Ribavirin for HCV Patient in Real Life Conditions." Asian Pacific Association Study of The Liver (APASL) Congress , 2014
ŞİRİN, G. Et Al. (2014) . "Is There Any Difference Between PEG IFN Alpha 2a or Alpha 2b Plus Ribavirin for HCV Patient in Real Life Conditions." Asian Pacific Association Study of The Liver (APASL) Congress .
@conferencepaper{conferencepaper, author={GÖKTUĞ ŞİRİN Et Al. }, title={Is There Any Difference Between PEG IFN Alpha 2a or Alpha 2b Plus Ribavirin for HCV Patient in Real Life Conditions}, congress name={Asian Pacific Association Study of The Liver (APASL) Congress}, city={}, country={}, year={2014}}